Biotalys Valuation

BTLS Stock   2.97  0.07  2.41%   
Based on Macroaxis valuation methodology, the firm appears to be fairly valued. Biotalys NV shows a prevailing Real Value of USD3.04 per share. The current price of the firm is USD2.97. Our model approximates the value of Biotalys NV from analyzing the firm fundamentals such as Return On Equity of -0.57, operating margin of (62.99) %, and Shares Outstanding of 30.96 M as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
2.97
Please note that Biotalys' price fluctuation is slightly risky at this time. Calculation of the real value of Biotalys NV is based on 3 months time horizon. Increasing Biotalys' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Biotalys stock is determined by what a typical buyer is willing to pay for full or partial control of Biotalys NV. Since Biotalys is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Biotalys Stock. However, Biotalys' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  2.97 Real  3.04 Hype  2.97 Naive  2.89
The intrinsic value of Biotalys' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Biotalys' stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
3.04
Real Value
4.97
Upside
Estimating the potential upside or downside of Biotalys NV helps investors to forecast how Biotalys stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Biotalys more accurately as focusing exclusively on Biotalys' fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
2.793.023.24
Details
Hype
Prediction
LowEstimatedHigh
1.042.974.90
Details
Naive
Forecast
LowNext ValueHigh
0.962.894.82
Details

Biotalys Total Value Analysis

Biotalys NV is currently projected to have takeover price of 172.6 M with market capitalization of 213.62 M, debt of , and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Biotalys fundamentals before making investing decisions based on enterprise value of the company

Biotalys Asset Utilization

One of the ways to look at asset utilization of Biotalys is to check how much profit was generated for every dollar of assets it reports. Biotalys NV shows a negative utilization of assets of -0.26 percent, losing USD0.002637 for each dollar of assets held by the firm. Inadequate asset utilization signifies that the company is being less effective with each dollar of assets it shows. Put another way, asset utilization of Biotalys NV shows how discouraging it operates for each dollar spent on its assets.

Biotalys Ownership Allocation

Biotalys holds a total of 30.96 Million outstanding shares. Biotalys NV retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

About Biotalys Valuation

The stock valuation mechanism determines Biotalys' current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Biotalys NV based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Biotalys. We calculate exposure to Biotalys's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Biotalys's related companies.

8 Steps to conduct Biotalys' Valuation Analysis

Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Biotalys' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Biotalys' valuation analysis, follow these 8 steps:
  • Gather financial information: Obtain Biotalys' financial statements, including balance sheets, income statements, and cash flow statements.
  • Determine Biotalys' revenue streams: Identify Biotalys' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
  • Analyze market data: Research Biotalys' industry and market trends, including the size of the market, growth rate, and competition.
  • Establish Biotalys' growth potential: Evaluate Biotalys' management, business model, and growth potential.
  • Determine Biotalys' financial performance: Analyze its financial statements to assess its historical performance and future potential.
  • Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
  • Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Biotalys' estimated value.
  • Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Note: This is a general outline, and different approaches and methods may be used depending on the type and size of the company being valued. We also recomment to seek professional assistance to ensure accuracy.

Additional Tools for Biotalys Stock Analysis

When running Biotalys' price analysis, check to measure Biotalys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotalys is operating at the current time. Most of Biotalys' value examination focuses on studying past and present price action to predict the probability of Biotalys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotalys' price. Additionally, you may evaluate how the addition of Biotalys to your portfolios can decrease your overall portfolio volatility.